How Smart Licensing of a Clinical-Stage Degrader Strengthened Oncology Pipeline
Case Studies
Fuld & Company
Objective A US-based biopharma company aimed to expand its immuno-oncology pipeline by in-licensing immuno-oncology strategies through a differentiated clinical-stage targeted […]